A few IMPDH2 inhibitors are currently FDA-approved, although not for the treatment of cancer; for example, ribavirin is used for the treatment of viral infections20,26 while mycophenolate mofetil is used as an immunosuppressant post organ transplant20,26. This evidence concerns the gene IMPDH2 and cancer.